You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
16 July 2026 - Clinical-stage biotechnology company Lakewood-Amedex Biotherapeutics Inc (NASDAQ:LABT) on Wednesday announced preclinical safety data for its Nu-3 gel formulation that establishes a strong foundation for clinical dose selection in an u...
16 July 2026 - Medical equipment company Vector Science & Therapeutics Corp (TSXV:PAIN) announced on Wednesday the expansion of its intellectual property portfolio to 15 patent applications developed and filed over approximately the past two year...
16 July 2026 - Intensity Therapeutics Inc (Nasdaq:INTS), a late-stage clinical biotechnology company, announced on Wednesday that new patients have been administered INT230-6 in the INVINCIBLE-4 Study in Switzerland.The study analyses INT230-6 given ...
15 July 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Wednesday that its Phase 3 KEYNOTE-C93 trial evaluating KEYTRUDA (pembrolizumab) met its primary endpoint of progression-free...
15 July 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), announced on Wednesday that the US Food and Drug Administration (FDA) has granted priority review to its supplemental Biologics License Applica...
15 July 2026 - Lynk Pharmaceuticals Co Ltd, a clinical-stage drug development company focused on immune and inflammatory diseases, announced on Tuesday the completion of patient enrolment in the Phase III clinical trial evaluating its core product ze...
15 July 2026 - Chinese pharmaceutical company Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HK:6990) announced on Tuesday that a Phase III clinical study (OptiTROP-Lung06) of its trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug con...